000 | 01209 a2200325 4500 | ||
---|---|---|---|
005 | 20250515004457.0 | ||
264 | 0 | _c20060228 | |
008 | 200602s 0 0 eng d | ||
022 | _a1083-7159 | ||
024 | 7 |
_a10.1634/theoncologist.10-90001-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBell, Richard | |
245 | 0 | 0 |
_aEfficacy of ibandronate in metastatic bone disease: review of clinical data. _h[electronic resource] |
260 |
_bThe oncologist _c2005 |
||
300 |
_a8-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIbandronic Acid |
650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
773 | 0 |
_tThe oncologist _gvol. 10 Suppl 1 _gp. 8-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.10-90001-8 _zAvailable from publisher's website |
999 |
_c15890508 _d15890508 |